SPL 3.00% 9.7¢ starpharma holdings limited

Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-28

  1. bid
    639 Posts.
    lightbulb Created with Sketch. 164
    Read the Principal Investigators comments? Specifically mentions how impressed he was by the benefits of Viraleze for protection against infection (prevention) and treatment of individuals (to reduce viral load, accelerate clearance and quicker recovery, regain sense of smell etc). Another independent commentator stated Viraleze protect people from becoming infected and demonstration of a significant treatment benefit.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
-0.003(3.00%)
Mkt cap ! $40.00M
Open High Low Value Volume
10.0¢ 10.0¢ 9.6¢ $44.81K 460.0K

Buyers (Bids)

No. Vol. Price($)
1 9800 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 239 1
View Market Depth
Last trade - 15.58pm 17/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.